160 related articles for article (PubMed ID: 27190598)
21. Design and Development of Novel Urea, Sulfonyltriurea, and Sulfonamide Derivatives as Potential Inhibitors of
Roy S; Mahapatra AD; Mohammad T; Gupta P; Alajmi MF; Hussain A; Rehman MT; Datta B; Hassan MI
Pharmaceuticals (Basel); 2020 Jun; 13(6):. PubMed ID: 32526899
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies.
Evangelisti C; Evangelisti C; Buontempo F; Lonetti A; Orsini E; Chiarini F; Barata JT; Pyne S; Pyne NJ; Martelli AM
Leukemia; 2016 Nov; 30(11):2142-2151. PubMed ID: 27461062
[TBL] [Abstract][Full Text] [Related]
23. Sphingolipids in pulmonary fibrosis.
Huang LS; Natarajan V
Adv Biol Regul; 2015 Jan; 57():55-63. PubMed ID: 25446881
[TBL] [Abstract][Full Text] [Related]
24. Revealing 2-dimethylhydrazino-2-alkyl alkynyl sphingosine derivatives as sphingosine kinase 2 inhibitors: Some hints on the structural basis for selective inhibition.
Corro-Morón M; Granell A; Ivanova V; Domingo E; Beltrán-Debón R; Barril X; Sanz MJ; Matheu MI; Castillón S; Díaz Y
Bioorg Chem; 2022 Apr; 121():105668. PubMed ID: 35219046
[TBL] [Abstract][Full Text] [Related]
25. Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening Hits.
Schnute ME; McReynolds MD; Carroll J; Chrencik J; Highkin MK; Iyanar K; Jerome G; Rains JW; Saabye M; Scholten JA; Yates M; Nagiec MM
J Med Chem; 2017 Mar; 60(6):2562-2572. PubMed ID: 28231433
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and evaluation of 2-aminothiazole derivatives as sphingosine kinase inhibitors.
Vogt D; Weber J; Ihlefeld K; Brüggerhoff A; Proschak E; Stark H
Bioorg Med Chem; 2014 Oct; 22(19):5354-67. PubMed ID: 25150091
[TBL] [Abstract][Full Text] [Related]
27. Drugging sphingosine kinases.
Santos WL; Lynch KR
ACS Chem Biol; 2015 Jan; 10(1):225-33. PubMed ID: 25384187
[TBL] [Abstract][Full Text] [Related]
28. In Silico Characterization of Structural Distinctions between Isoforms of Human and Mouse Sphingosine Kinases for Accelerating Drug Discovery.
Worrell BL; Brown AM; Santos WL; Bevan DR
J Chem Inf Model; 2019 May; 59(5):2339-2351. PubMed ID: 30844267
[TBL] [Abstract][Full Text] [Related]
29. ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium.
Tanfin Z; Serrano-Sanchez M; Leiber D
Cell Signal; 2011 Dec; 23(12):1997-2004. PubMed ID: 21803151
[TBL] [Abstract][Full Text] [Related]
30. Role of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Axis in Hepatocellular Carcinoma.
Maceyka M; Rohrbach T; Milstien S; Spiegel S
Handb Exp Pharmacol; 2020; 259():3-17. PubMed ID: 31321542
[TBL] [Abstract][Full Text] [Related]
31. Sphingosine kinase 1/sphingosine-1-phosphate (S1P)/S1P receptor axis is involved in ovarian cancer angiogenesis.
Dai L; Liu Y; Xie L; Wu X; Qiu L; Di W
Oncotarget; 2017 Sep; 8(43):74947-74961. PubMed ID: 29088837
[TBL] [Abstract][Full Text] [Related]
32. Impairment of chemical hypoxia-induced sphingosine kinase-1 expression and activation in rheumatoid arthritis synovial fibroblasts: A signature of exhaustion?
Zhao C; Amiable N; Laflamme M; Marsolais D; Di Battista JA; Fernandes MJ; Bourgoin SG
Biochem Pharmacol; 2019 Jul; 165():249-262. PubMed ID: 30753812
[TBL] [Abstract][Full Text] [Related]
33. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose.
Huang K; Huang J; Chen C; Hao J; Wang S; Huang J; Liu P; Huang H
Cell Signal; 2014 Mar; 26(3):629-38. PubMed ID: 24342046
[TBL] [Abstract][Full Text] [Related]
34. The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.
Zheng X; Li W; Ren L; Liu J; Pang X; Chen X; Kang D; Wang J; Du G
Pharmacol Ther; 2019 Mar; 195():85-99. PubMed ID: 30347210
[TBL] [Abstract][Full Text] [Related]
35. Identification of selective inhibitors of sphingosine kinases 1 and 2 through a structure-activity relationship study of 4-epi-jaspine B.
Ohno H; Honda M; Hamada N; Miyagaki J; Iwata A; Otsuki K; Maruyama T; Nakamura S; Nakanishi I; Inuki S; Fujii N; Oishi S
Bioorg Med Chem; 2017 Jun; 25(12):3046-3052. PubMed ID: 28408190
[TBL] [Abstract][Full Text] [Related]
36. Sphingosine kinase 1 in viral infections.
Carr JM; Mahalingam S; Bonder CS; Pitson SM
Rev Med Virol; 2013 Mar; 23(2):73-84. PubMed ID: 22639116
[TBL] [Abstract][Full Text] [Related]
37. Crystal Structure of Sphingosine Kinase 1 with PF-543.
Wang J; Knapp S; Pyne NJ; Pyne S; Elkins JM
ACS Med Chem Lett; 2014 Dec; 5(12):1329-33. PubMed ID: 25516793
[TBL] [Abstract][Full Text] [Related]
38. Mobilization studies in mice deficient in sphingosine kinase 2 support a crucial role of the plasma level of sphingosine-1-phosphate in the egress of hematopoietic stem progenitor cells.
Adamiak M; Chelvarajan L; Lynch KR; Santos WL; Abdel-Latif A; Ratajczak MZ
Oncotarget; 2017 Sep; 8(39):65588-65600. PubMed ID: 29029455
[TBL] [Abstract][Full Text] [Related]
39. Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer's disease brain.
Dominguez G; Maddelein ML; Pucelle M; Nicaise Y; Maurage CA; Duyckaerts C; Cuvillier O; Delisle MB
Acta Neuropathol Commun; 2018 Apr; 6(1):25. PubMed ID: 29615132
[TBL] [Abstract][Full Text] [Related]
40. Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System.
Cannavo A; Liccardo D; Komici K; Corbi G; de Lucia C; Femminella GD; Elia A; Bencivenga L; Ferrara N; Koch WJ; Paolocci N; Rengo G
Front Pharmacol; 2017; 8():556. PubMed ID: 28878674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
